Impact of a Reinforced Graphene Oxide and Alginate Hydrogel with an Oxygen Releasing System on the Biocompatibility of Pancreatic β‐Cells for Diabetes Therapy
Macromolecular Bioscience · 2026
DOI: 10.1002/mabi.70227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, 2026. Verfasst von Elías Cuartas-Gómez und 2 weiteren Autor:innen. Beteiligte Einrichtung: CICTA Research Group, Universidad Industrial de Santander, Bucaramanga, Colombia. Hauptthemen laut MEDLINE: Alginates, Graphite, Insulin-Secreting Cells, Oxygen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministerio de Ciencia, Tecnología e innovación de Colombia-Minciencias, Universidad Industrial de Santander, Vicerrectoría De Investigación of the Universidad Industrial De Santander.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 1 diabetes is characterized by autoimmune destruction of pancreatic β‐cells, resulting in insulin deficiency and impaired blood glucose regulation. Cell encapsulation using alginate‐based hydrogels offers immunoprotection but faces challenges due to low oxygen solubility, compromising cell survival to restore vascularization after implantation. To address this, we developed an alginate hydrogel reinforced with graphene oxide (ALGO) and integrated calcium peroxide (CPO) as an oxygen‐releasing system, stabilized with poly‐L‐lysine (PLL). Physicochemical and mechanical characterization confirmed incorporation of all components and improved elasticity with increasing CPO concentration. Hydrogels maintained structural stability for eight days and released oxygen throughout this period. Biocompatibility assays revealed that ALGO containing 0.25% CPO (0.25CPO) preserved cell viability and proliferation for 96 h, while 1% CPO negatively affected survival. Oxygen consumption analysis showed that 0.25CPO sustained mitochondrial respiration and enhanced maximal respiratory capacity. Glucose‐stimulated insulin secretion demonstrated that 0.25CPO maintained functional responsiveness under low and high glucose conditions. These findings indicate that 0.25CPO hydrogels provide controlled oxygen delivery, mechanical stability, and improved biocompatibility, making them a promising platform for pancreatic β‐cell encapsulation and future preclinical applications in type 1 diabetes therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CICTA Research Group, Universidad Industrial de Santander, Bucaramanga, Colombia.
- GIMAT Research group, Escuela de Ingeniería Metalúrgica y Ciencia de los Materiales, Universidad Industrial de Santander, Bucaramanga, Colombia.
- Centro de Cromatografía y Espectrometría de Masas, CROM-MASS, Universidad Industrial de Santander, Bucaramanga, Colombia.
ORCID-Profile: Elías Cuartas-Gómez, Oscar Vargas-Ceballos, Natalia Moreno-Castellanos
Förderung
- Ministerio de Ciencia, Tecnología e innovación de Colombia-Minciencias
- Universidad Industrial de Santander
- Vicerrectoría De Investigación of the Universidad Industrial De Santander
Zitieren
APA
Cuartas-Gómez, E., Vargas-Ceballos, O., & Moreno-Castellanos, N. (2026). Impact of a Reinforced Graphene Oxide and Alginate Hydrogel with an Oxygen Releasing System on the Biocompatibility of Pancreatic β‐Cells for Diabetes Therapy. Macromolecular Bioscience. https://doi.org/10.1002/mabi.70227
Vancouver
Cuartas-Gómez E, Vargas-Ceballos O, Moreno-Castellanos N. Impact of a Reinforced Graphene Oxide and Alginate Hydrogel with an Oxygen Releasing System on the Biocompatibility of Pancreatic β‐Cells for Diabetes Therapy. Macromolecular Bioscience. 2026. doi:10.1002/mabi.70227
BibTeX
@article{CuartasGmez2026,
author = {Cuartas-Gómez, Elías and Vargas-Ceballos, Oscar and Moreno-Castellanos, Natalia},
title = {Impact of a Reinforced Graphene Oxide and Alginate Hydrogel with an Oxygen Releasing System on the Biocompatibility of Pancreatic β‐Cells for Diabetes Therapy},
journal = {Macromolecular Bioscience},
year = {2026},
doi = {10.1002/mabi.70227}
}
EUVIMED